ONWARD® Medical Annonce la Cotation de ses Titres sur le Marché Euronext Paris
20 sept. 2024 13h45 HE
|
ONWARD Medical NV
La société a des racines françaises et des liens significatifs avec la France La société collabore étroitement avec le CEA-Clinatec, institut de recherche biomédicale de renommée mondiale financé par...
ONWARD® Medical Announces Third Implant of Brain-Computer Interface (BCI) System to Restore Movement after Spinal Cord Injury
19 sept. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD® Medical Announces Third Implant of Brain-Computer Interface (BCI) System to Restore Movement after Spinal Cord Injury
ONWARD® Medical annonce le troisième implant de son système d'interface cerveau-machine (BCI) pour restaurer le mouvement après une lésion de la moelle épinière
19 sept. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD® Medical annonce le troisième implant de son système d'interface cerveau-machine pour restaurer le mouvement après une lésion de la moelle épinière
ONWARD® Medical Reports Half Year 2024 Results and Provides a Business Update
10 sept. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD® Medical Reports Half Year 2024 Results and Provides a Business Update
ONWARD® Medical and Partners Awarded Christopher & Dana Reeve Foundation Grant to Further Study Brain-Computer Interface System
03 sept. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD® Medical and Partners Awarded Christopher & Dana Reeve Foundation Grant to Further Study Brain-Computer Interface System
ONWARD® Medical Schedules Webcast to Provide Half-Year 2024 Business Update
27 août 2024 12h53 HE
|
ONWARD Medical NV
ONWARD® Medical Schedules Webcast to Provide Half-Year 2024 Business Update
ONWARD® Medical Reaffirms 2024 Strategic Priorities and Releases Unaudited Q2 Financial Highlights
05 août 2024 17h47 HE
|
ONWARD Medical NV
ONWARD® Medical Reaffirms 2024 Strategic Priorities and Releases Unaudited Q2 Financial Highlights
ONWARD® Medical Publishes Annual Sustainability Summary
17 juil. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD® Medical Publishes Annual Sustainability Summary
ONWARD® Medical Announces Publication Highlighting Evidence-based Programming for ARC-EX® Therapy
09 juil. 2024 13h18 HE
|
ONWARD Medical NV
ONWARD® Medical Announces Publication Highlighting Evidence-based Programming for ARC-EX® Therapy
ONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC
28 juin 2024 17h53 HE
|
ONWARD Medical NV
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Runway Growth Capital LLC is a leading U.S.-based specialty...